MABVAX THERAPEUTICS HOLDINGS, INC. 4

4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Jun 14, 2017

Insider Transaction Report

Form 4
Period: 2017-06-12
Transactions
  • Award

    Option to Purchase Common Stock

    2017-06-12$1.57/sh+20,000$31,40020,000 total
    Exercise: $1.57Exp: 2027-06-12Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Automatic Annual Grant to Non-Employee Director pursuant to the Issuer's Non-Employee Director Compensation Policy.
  • [F2]Option vests and becomes exercisable one year after the date of grant, subject to recipient's continued service on the Company's Board of Directors.

Documents

1 file
  • 4
    form4-06142017_010649.xmlPrimary